Financials Trans Genic Inc.

Equities

2342

JP3635720000

Department Stores

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
248 JPY -5.70% Intraday chart for Trans Genic Inc. +10.22% -4.62%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 8,193 8,457 5,037 10,577 7,148 5,597
Enterprise Value (EV) 1 7,199 7,738 5,002 9,540 4,343 4,554
P/E ratio 381 x 41.4 x -11.4 x 19.4 x 3.89 x -13.7 x
Yield - - - 0.49% 0.71% 0.9%
Capitalization / Revenue 2.28 x 0.98 x 0.46 x 0.96 x 0.57 x 0.49 x
EV / Revenue 2 x 0.89 x 0.45 x 0.86 x 0.35 x 0.4 x
EV / EBITDA 34.9 x 16.8 x 12.4 x 8.32 x 2.1 x 29 x
EV / FCF -17.6 x -221 x -11.6 x 10.6 x 6.79 x -4.44 x
FCF Yield -5.68% -0.45% -8.6% 9.45% 14.7% -22.5%
Price to Book 1.93 x 1.75 x 1.14 x 2.15 x 1.09 x 0.93 x
Nbr of stocks (in thousands) 15,909 17,155 17,368 17,368 16,818 16,858
Reference price 2 515.0 493.0 290.0 609.0 425.0 332.0
Announcement Date 6/21/18 6/20/19 6/18/20 6/24/21 6/24/22 6/22/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 3,601 8,674 11,046 11,046 12,576 11,429
EBITDA 1 206 460 403 1,147 2,064 157
EBIT 1 63 270 174 896 1,837 -25
Operating Margin 1.75% 3.11% 1.58% 8.11% 14.61% -0.22%
Earnings before Tax (EBT) 1 14 202 -249 695 2,767 -331
Net income 1 20 202 -440 546 1,876 -409
Net margin 0.56% 2.33% -3.98% 4.94% 14.92% -3.58%
EPS 2 1.350 11.91 -25.33 31.44 109.3 -24.28
Free Cash Flow 1 -409.2 -35 -430.2 901.5 639.4 -1,026
FCF margin -11.36% -0.4% -3.9% 8.16% 5.08% -8.98%
FCF Conversion (EBITDA) - - - 78.6% 30.98% -
FCF Conversion (Net income) - - - 165.11% 34.08% -
Dividend per Share - - - 3.000 3.000 3.000
Announcement Date 6/21/18 6/20/19 6/18/20 6/24/21 6/24/22 6/22/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 5,191 4,680 6,702 2,943 2,470 5,542 2,922 3,280 6,377 3,366
EBITDA - - - - - - - - - -
EBIT 1 45 41 1,602 131 -16 134 19 106 88 -36
Operating Margin 0.87% 0.88% 23.9% 4.45% -0.65% 2.42% 0.65% 3.23% 1.38% -1.07%
Earnings before Tax (EBT) 1 6 5 1,540 -149 -15 156 188 128 94 -87
Net income 1 -41 25 981 -179 -25 54 128 78 48 -86
Net margin -0.79% 0.53% 14.64% -6.08% -1.01% 0.97% 4.38% 2.38% 0.75% -2.55%
EPS 2 -2.410 1.470 56.56 -9.990 -1.530 3.260 7.550 4.640 2.870 -5.140
Dividend per Share - - - - - - - - - -
Announcement Date 11/8/19 11/12/20 11/12/21 2/14/22 8/12/22 11/11/22 2/10/23 8/10/23 11/10/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 994 719 35 1,037 2,805 1,043
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -409 -35 -430 902 639 -1,026
ROE (net income / shareholders' equity) 0.53% 4.38% -9.46% 11.5% 31.9% -6.88%
ROA (Net income/ Total Assets) 0.8% 2.72% 1.55% 6.79% 11.9% -0.15%
Assets 1 2,498 7,427 -28,416 8,038 15,815 276,351
Book Value Per Share 2 266.0 282.0 254.0 283.0 388.0 357.0
Cash Flow per Share 2 109.0 73.60 92.30 174.0 275.0 205.0
Capex 1 74 320 256 145 532 306
Capex / Sales 2.05% 3.69% 2.32% 1.31% 4.23% 2.68%
Announcement Date 6/21/18 6/20/19 6/18/20 6/24/21 6/24/22 6/22/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 2342 Stock
  4. Financials Trans Genic Inc.